Polydatin Alleviates Non-Alcoholic Fatty Liver Disease in Rats by Inhibiting the Expression of TNF-α and SREBP-1c

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2012.1015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Expression of Resistin in the Liver of Patients With Non-Alcoholic Fatty Liver Disease

Polish Journal of Pathology
MedicineForensic MedicinePathology
2017English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

Inhibition of CCL19 Benefits Non‑alcoholic Fatty Liver Disease by Inhibiting TLR4/NF‑κB‑p65 Signaling

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Treatment of Non-Alcoholic Fatty Liver Disease

Postgraduate Medical Journal
Medicine
2006English

Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats

Antioxidants
BiochemistryClinical BiochemistryCell BiologyMolecular BiologyPhysiology
2019English

Differences in the Genetic Backgrounds of Patients With Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease

JGH Open
HepatologyGastroenterology
2018English

Headway and Hurdles in Non-Alcoholic Fatty Liver Disease

Lancet Gastroenterology and Hepatology, The
HepatologyGastroenterology
2020English

Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Hepatology
MedicineHepatology
2019English

Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy